Exclusive: Tesla signs $4.3 billion LGES battery deal, source says, reducing China reliance
The lithium iron phosphate (LFP) batteries will be supplied from LGES's U.S. factory in Michigan, the person said on condition of anonymity because the details were not public.
LGES announced earlier on Wednesday that it had signed a $4.3 billion contract to supply LFP batteries over three years globally, without identifying the customer or saying if they would be used in vehicles or energy storage systems.
The South Korean company said last week it would try to offset sluggish electric vehicle demand by increasing sales of storage batteries thanks to a global surge in demand for power driven by data centres to train artificial intelligence.
"In accordance with our agreement, we are unable to disclose the customer's identity due to confidentiality obligations," LGES told Reuters. Tesla did not immediately respond to a request for comment.
Tesla Chief Financial Officer Vaibhav Taneja said in April that U.S. tariffs had an "outsized" impact on its energy business, since it sources LFP batteries from China.
"We will also be working on securing additional supply chain from non-China-based suppliers, but it will take time," he said.
Tesla this week also announced a $16.5 billion deal to buy chips from Samsung Electronics' (005930.KS), opens new tab factory in Texas as South Korean companies expand their U.S. presence to meet local demand.
Three South Korean cabinet-level officials met U.S. Commerce Secretary Howard Lutnick in Washington in a push to close a trade deal ahead of an August 1 deadline for 25% tariffs on U.S. imports from South Korea to kick in, Seoul said on Wednesday.
LGES is one of the few U.S. producers of LFP batteries, a battery chemistry long dominated by Chinese rivals that have little presence in the U.S. market.
It started production of LFP batteries at its Michigan factory in May. The company said it was considering converting some electric vehicle battery production lines in the United States to cater to energy storage systems in response to slowing EV demand.
LGES said the contract would last from August 2027 to July 2030 and included an option to extend the deal period by up to seven years and to increase supply volumes depending on discussions with its customer.
"Other players, including South Korean firms like Samsung SDI and SK On, have yet to enter the U.S. LFP market, allowing LGES to enjoy a first-mover advantage," said Cho Hyun-ryul, a senior analyst at Samsung Securities. "While rivals have announced plans, LGES remains the only one actively producing at scale."
Tesla's energy storage and generation business accounts for just over 10% of its revenue but it has been a bright spot for the company as it struggles with slowing car sales and upcoming cuts to U.S. government support for EVs.
"Energy is growing really well despite headwinds from tariffs and various supply chain challenges," Tesla CEO Elon Musk said on an earnings call last week. "I think not that many people appreciate just how gigantic the scale of battery demand is."
Tesla has said its first LFP cell manufacturing facility will be online by the end of the year, but the in-house factory in Nevada will likely account for a small portion of its demand.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
32 minutes ago
- Reuters
Wall Street stocks outperform Europe on megacap earnings boost
NEW YORK/ LONDON, July 31 (Reuters) - Wall Street outperformed European equities on Thursday, boosted by megacap earnings reports, even as data showed signs of rising inflation and investors watched for last-minute trade deals ahead of U.S. President Donald Trump's August 1 deadline. U.S. Treasury yields briefly pared declines in choppy trading after data showed that U.S. inflation in June as tariffs on imports started raising the cost of some goods, supporting economists' expectations that price pressures would pick up in the second half of the year. The Federal Reserve kept rates steady on Wednesday, and chair Jerome Powell said that the central bank needed to wait for more data before deciding whether to adjust rates in September, drawing further criticism from Trump on Thursday. "Anybody hoping for the Fed to move more aggressively in the near term continues to be disappointed that it comes back to both the inflation and the job story. The PCE data this morning reinforced the inflation worries the Fed still has and helps explain why it's in no hurry to move at this point," said Jim Baird, Chief Investment Officer with Plante Moran Financial Advisors. But while Powell's comments had sent equities lower on Wednesday, U.S. indexes rebounded on Thursday after better-than-expected results from Microsoft (MSFT.O), opens new tab and Meta Platforms (META.O), opens new tab. "A couple of solid earnings reports last night suggest that one of the key themes that's been driving the stock market this year is still seemingly intact. You've seen a nice rebound in tech today, or nice surge in tech today. "The AI theme, the enthusiasm around the technology sector still appears to be intact. So that's a positive catalyst for the market," said Baird. On Wall Street, indexes lost some steam as the session progressed. At 11:14 a.m., the Dow Jones Industrial Average (.DJI), opens new tab fell 123.28 points, or 0.28%, to 44,338.00. The S&P 500 (.SPX), opens new tab rose 13.57 points, or 0.21%, to 6,376.47 and the Nasdaq Composite (.IXIC), opens new tab rose 119.18 points, or 0.56%, to 21,248.86, both around session lows. In Europe, however, the broad Stoxx 600 (.STOXX), opens new tab benchmark was weighed down by miners after U.S. September Comex copper futures fell 22%, the biggest decline on record, after Trump said the U.S. would impose a 50% tariff on copper pipes and wiring. The pan-European STOXX 600 (.STOXX), opens new tab index was down 0.73% while MSCI's gauge of stocks across the globe (.MIWD00000PUS), opens new tab fell 1.07 points, or 0.11%, to 933.26. Earlier, Chinese stocks also retreated after official PMI gauges showed weaker than expected economic activity in July. China's blue chip CSI 300 had ended 1.8% lower, its biggest single day drop since April 7, and Hong Kong's (.HSI), opens new tab index closed 1.6% lower. In currencies, the U.S. dollar had a mixed performance on the day. The dollar index , which measures it against a basket of currencies, including the yen and the euro, rose 0.05% to 99.83. The euro was up 0.34% at $1.1443. But against the Japanese yen , the dollar strengthened 0.59% to 150.39. The Bank of Japan held interest rates steady and increased its inflation forecast. The Korean won weakened 0.2% against the dollar to 1,395.78 per dollar after rising earlier following Trump's announcement that the U.S. would charge a 15% tariff on imports from South Korea, which would in return invest $350 billion in U.S. projects and purchase $100 billion in U.S. energy products. In Treasuries, the yield on benchmark U.S. 10-year notes fell 4.6 basis points to 4.332%, from 4.378% late on Wednesday while the 30-year bond yield fell 5.1 basis points to 4.8624%. The two-year note yield, which typically moves in step with interest rate expectations for the Federal Reserve, fell 1.9 basis points to 3.918%, from 3.937% late on Wednesday. In oil markets, prices fell after rising for the prior three sessions as investors weighed the supply risks from Trump's push for a to the war in Ukraine through more tariffs and a surprise build in U.S. crude stocks put pressure on prices. U.S. crude fell 1.71% to $68.79 a barrel and Brent fell to $72.47 per barrel, down 1.04% on the day. Gold prices rose as traders turned to the safe haven asset amid ongoing tariff uncertainty, ahead of the August 1 tariff deadline. Spot gold rose 0.63% to $3,295.33 an ounce.
Reuters
an hour ago
- Reuters
Medical products maker Baxter cuts 2025 forecast; shares plunge to 19-year low
July 31 (Reuters) - Baxter International (BAX.N), opens new tab slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering fallout from Hurricane Helene and continued hospital fluid conservation weighed on its medical products business. Shares of the medical products maker tumbled about 23% in morning trading, hitting their lowest level since 2006. Noting the "softness in demand" for IV fluids - used to deliver medications or nutrients directly into a patient's bloodstream - CFO Joel Grade told analysts, "While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential downside risks." Baxter has voluntarily halted shipments of its Novum IQ Large Volume Pump after reports of two deaths and multiple injuries, and said it does not expect to resume shipments before year-end. The medical products maker now expects adjusted earnings of between $2.42 and $2.52 per share, down from its prior view of $2.47 to $2.55 per share. Analysts had expected $2.52 per share. Hurricane Helene damaged Baxter's North Carolina plant last year, disrupting IV solution production and prompting hospitals to conserve fluids. While supply has since been restored, demand remains subdued, the company said. The company said volume declines in IV solutions significantly impacted operating income and profit per share, with the outlook assuming fluid conservation to remain at 20% below normal levels for the rest of 2025. "Many investors had feared this scenario given the lack of a pre-announcement following a new CEO in early July," JPMorgan analyst Robbie Marcus said. Second-quarter adjusted earnings came in at 59 cents per share, missing estimates of 61 cents. Revenue was $2.81 billion, just shy of the $2.82 billion expected. Baxter's pharmaceuticals unit also underperformed, with injectable drug sales down 1% and anesthesia sales falling by low double digits globally. On tariffs, Baxter lowered its estimated 2025 impact to $40 million, from a previous $60 million to $70 million.
The Guardian
an hour ago
- The Guardian
The Guardian view on Trump's tariffs: both a political and an economic threat
Donald Trump's 1 August tariffs deadline did what it was always intended to do. It kept the markets and the nations guessing amid last-minute uncertainty. It attempted to reassert the global heft of the United States economy to take on and master all comers. And it placed President Trump at the centre of the media story, where he always insists on being. In the event, there were some last-minute agreements struck this week, few of them fair or rational in trade terms, most of them motivated by the desire to generate some commercial order. Some conflicts are still in the balance. There were 11th-hour court challenges too, disputing the president's very right to play the trade war game in this way. Even now, no one, probably including Mr Trump himself, knows whether this is his administration's last word on US tariffs. Almost certainly not. That's because Mr Trump's love of tariffs is always more about the assertion of political clout rather than economic power. Mr Trump's antipathy towards the European Union drives one example. The pact agreed by Ursula von der Leyen in Scotland last weekend underlines that the EU's aspirations as a global economic superpower exceed its actual clout. The EU could not prevent Mr Trump making European goods 15% more expensive if they sell on US markets. Nor could it stop Mr Trump getting EU tariffs on US goods withdrawn. Equally eloquent about the global balance of economic power is that Mr Trump has not been able to force China to bend the knee in the manner of the EU. China has responded aggressively to Trump's tariff threats, retaliating with tariffs of its own and blocking the sale of commodities, including rare-earth minerals, that the US most covets. Unsurprisingly, this standoff has not produced one of Mr Trump's so-called deals. Friday's deadline has been reset for later in the month. It would be no surprise if it was eventually pushed back further. Mr Trump is not imposing tariffs on the rest of the world in order to promote global trade or even to boost the US economy. He is doing it, in part, because Congress has delegated this power to him, allowing the president to impose or waive tariffs at will. He uses this power for many purposes. These include raising government income without congressional oversight and also, because tariffs are regressive, shifting the tax burden away from the very rich, like Mr Trump himself, on to the middle and working class. But economics also comes way down the field in the list of reasons why Mr Trump is wielding the tariff weapon internationally. US talks with Brazil – with which the US runs a trade surplus, not a deficit – have been hijacked by Mr Trump's grievance over the prosecution of its former president Jair Bolsonaro for trying to overturn his 2022 election defeat. Talks with India are deadlocked because Mr Trump wants to penalise Delhi for buying energy and weapons from Russia. Those with Canada have been hit by Mr Trump's objections to Ottawa's plan to recognise Palestine. The ultimate test of the policy, however, will indeed be economic. For now, financial markets appear to have decided that Mr Trump's tariffs are manageable. If tariffs now raise the cost of goods on US high streets, slowing growth and feeding inflation, as they may, the wider market response could change quickly. In that event, the mood among American voters might even shift too.
